Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Ultragenyx Pharmaceutical Inc.
Current Parent Company: Ultragenyx Pharmaceutical
Penalty: $6,000,000
Year: 2023
Date: December 21, 2023
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Pharmaceutical company Ultragenyx Pharmaceutical Inc. agreed to pay $6 million to resolve allegations that it caused the submission of false claims to Medicare and Medicaid, in violation of the False Claims Act, by paying for free genetic tests, plus a separate fee to receive test result information for marketing purposes, to collectively induce prescriptions of its drug Crysvita and referrals of health care providers to Ultragenyx for the furnishing or arranging for the furnishing of Crysvita.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: California
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.